Cargando…
Treatment-shortening regimens for tuberculosis: updates and future priorities
In the past 2 years, remarkable advances have been made in shortening tuberculosis (TB) treatment. In particular, four clinical trials (Study 31/A5349, Nix-TB, ZeNix and TB-PRACTECAL) have provided evidence of the efficacy of regimens based on new and repurposed drugs: the 4-month regimen for drug-s...
Autores principales: | Saluzzo, Francesca, Adepoju, Victor Abiola, Duarte, Raquel, Lange, Christoph, Phillips, Patrick P.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567072/ https://www.ncbi.nlm.nih.gov/pubmed/37830101 http://dx.doi.org/10.1183/20734735.0028-2023 |
Ejemplares similares
-
Ending the TB pandemic: the urgency of a new and improved TB vaccine and the World Health Organization's TB Vaccine Accelerator Council
por: Adepoju, Victor Abiola, et al.
Publicado: (2023) -
Tuberculosis: current challenges and beyond
por: Villar-Hernández, Raquel, et al.
Publicado: (2023) -
Implementing molecular tuberculosis diagnostic methods in limited-resource and high-burden countries
por: Vasiliu, Anca, et al.
Publicado: (2022) -
Rolling out new anti-tuberculosis drugs without diagnostic capacity
por: Ness, Tara, et al.
Publicado: (2023) -
Primary Care Patient Records in the United Kingdom: Past, Present, and Future Research Priorities
por: McMillan, Brian, et al.
Publicado: (2018)